[go: up one dir, main page]

MA28980B1 - 1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS - Google Patents

1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS

Info

Publication number
MA28980B1
MA28980B1 MA29689A MA29689A MA28980B1 MA 28980 B1 MA28980 B1 MA 28980B1 MA 29689 A MA29689 A MA 29689A MA 29689 A MA29689 A MA 29689A MA 28980 B1 MA28980 B1 MA 28980B1
Authority
MA
Morocco
Prior art keywords
hetero
inhibitors
heterocyclylethanes
arylethanes
tetra
Prior art date
Application number
MA29689A
Other languages
French (fr)
Inventor
Mark T Bilodeau
Zhicai Wu
John Hartnett
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MA28980B1 publication Critical patent/MA28980B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention porte sur des composés représentés par la structure (1) utiles en tant qu'inhibiteurs de canal potassique dans le traitement des arythmies cardiaques et autres maladies similaires.This invention relates to compounds represented by structure (1) useful as potassium channel inhibitors in the treatment of cardiac arrhythmias and other similar diseases.

MA29689A 2004-07-29 2007-02-21 1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS MA28980B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
MA28980B1 true MA28980B1 (en) 2007-11-01

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29689A MA28980B1 (en) 2004-07-29 2007-02-21 1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS

Country Status (15)

Country Link
KR (1) KR20070043985A (en)
AR (1) AR049847A1 (en)
BR (1) BRPI0513793A (en)
CR (1) CR8876A (en)
EC (1) ECSP077208A (en)
IL (1) IL180846A0 (en)
MA (1) MA28980B1 (en)
MX (1) MX2007001188A (en)
NO (1) NO20071107L (en)
PE (1) PE20060382A1 (en)
RU (1) RU2344134C2 (en)
TW (1) TW200607493A (en)
UA (1) UA88018C2 (en)
WO (1) WO2006028590A1 (en)
ZA (1) ZA200700477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102427806B (en) * 2009-03-18 2015-11-25 麦迪库瑞国际公司 Transdermal pharmaceutical formulation and administration of tirofiban
NZ703632A (en) 2012-06-11 2016-01-29 Bristol Myers Squibb Co Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2140865B2 (en) * 1971-08-14 1979-10-11 Bayer Ag, 5090 Leverkusen 1-imidazolyl-methanephosphonic acid ester, process for their preparation and medicaments containing them
DE19951701A1 (en) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Use of 2-imidazolyl-substituted carbinols for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions
ATE400551T1 (en) * 2002-01-04 2008-07-15 Neurosearch As POTASSIUM CHANNEL MODULATORS

Also Published As

Publication number Publication date
MX2007001188A (en) 2007-03-21
BRPI0513793A (en) 2008-05-13
PE20060382A1 (en) 2006-05-15
ZA200700477B (en) 2009-08-26
RU2344134C2 (en) 2009-01-20
RU2007107408A (en) 2008-09-10
IL180846A0 (en) 2007-06-03
CR8876A (en) 2007-08-28
UA88018C2 (en) 2009-09-10
ECSP077208A (en) 2007-02-28
WO2006028590A1 (en) 2006-03-16
KR20070043985A (en) 2007-04-26
TW200607493A (en) 2006-03-01
NO20071107L (en) 2007-04-19
AR049847A1 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
MA29817B1 (en) PROLINAMIDE DERIVATIVES AS MODULATORS OF THE SODIUM CHANNEL
WO2003103663A3 (en) SUBSTITUTED PYRROLINES AS KINASE INHIBITORS
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
ATE440087T1 (en) 2,4-DIAMINOPYRIMIDENE DERIVATIVES THAT ARE SUITABLE AS INHIBITORS OF PKC-THETA
EP1581656A4 (en) MODULATION OF THE EXPRESSION OF HIF1a AND HIF2a
MA28935B1 (en) PREPARATION AND USE OF BIPHENYL-4-YL CARBONYLAMINO ACID DERIVATIVES IN THE TREATMENT OF OBESITY
BRPI0408369A (en) indole derivatives useful for treating disease
TNSN06228A1 (en) Compounds and methods of use
MA30427B1 (en) BICYCLIC DERIVATIVES USED AS CETP INHIBITORS
EP1796669A4 (en) AMINOPIPERIDINES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV FOR THE TREATMENT OR PREVENTION OF DIABETES
MA32257B1 (en) Hydroxymethyl pyrrolidines as agonists of beta-3 adrenergic receptors.
PT1543011E (en) COMPOSITION OF TIENOPYROLYL AND FURANOPYROLYL AND ITS USE AS LIGANDS OF HISTAMINE H4 RECEPTOR
DE602004024572D1 (en) COMPOSITIONS SUITED AS INHIBITORS OF PROTEIN KINASES
EA201370001A1 (en) ANTI-VIRAL COMPOSITIONS FOR LOCAL APPLICATION
TW200730515A (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
BG66084B1 (en) CYCLOPENTANIDONOLS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND USE OF THEM
EA200700934A1 (en) PYRIMIDINE DERIVATIVES AND THEIR APPLICATION AS CB2 MODULATORS
EA200301232A1 (en) NEW ARYL SULPHONAMIDE CONNECTIONS AND THEIR APPLICATION FOR TREATMENT OF OBESITY, TYPE II DIABETES AND CENTRAL NERVOUS DISORDERS
EP1562897A4 (en) PHENYLCARBOXAMIDE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MY142988A (en) Novel aminobenzophenone compounds
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
EP2091328A4 (en) BETA-SECRETASE INHIBITORY SPIROPIPERIDINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
BRPI0508537A (en) Ion channel modulators
EA200601217A1 (en) NEW CONDENSED PYRROCARBAZOLES